Page last updated: 2024-12-07
rmi 15731
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
RMI 15731: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 100549 |
| CHEMBL ID | 3273833 |
| SCHEMBL ID | 8413515 |
| MeSH ID | M0076776 |
Synonyms (20)
| Synonym |
|---|
| nsc317936 |
| nsc-317936 |
| 54857-96-4 |
| 1-(5-(tetradecyloxy)-2-furanyl)ethanone |
| rmi 15,731 |
| 1-(5-tetradecoxy-2-furyl)ethanone |
| rmi-15731 |
| rmi 15731 |
| unii-47e4gm277b |
| 47e4gm277b , |
| nsc 317936 |
| CHEMBL3273833 |
| 5-(tetradecyloxy)-2-furyl methyl ketone |
| MMOTUYBUAZJWRU-UHFFFAOYSA-N |
| 1-(5-tetradecyloxy-2-furanyl)ethanone |
| SCHEMBL8413515 |
| ethanone, 1-(5-(tetradecyloxy)-2-furanyl)- |
| DTXSID20203339 |
| Q27259048 |
| PD161547 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (3)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1147276 | Hypolipidemic activity in Wistar rat assessed as reduction in plasma cholesterol level at 499 umol/kg/day administered through diet for 4 days | 1977 | Journal of medicinal chemistry, Jun, Volume: 20, Issue:6 | 5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids. |
| AID1147175 | Hypolipidemic activity in Wistar rat assessed as reduction in plasma triglyceride level at 499 umol/kg/day administered through diet for 4 days | 1977 | Journal of medicinal chemistry, Jun, Volume: 20, Issue:6 | 5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids. |
| AID1147364 | Increase in liver weight in Wistar rat at 499 umol/kg/day administered through diet for 4 days | 1977 | Journal of medicinal chemistry, Jun, Volume: 20, Issue:6 | 5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.66
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (20.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||